Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Bannerman Wealth Management Group »

Alnylam Pharmaceuticals shares owned by Bannerman Wealth Management Group

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Bannerman Wealth Management Group from 13F filings

Historical chart of Bannerman Wealth Management Group investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Bannerman Wealth Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Bannerman Wealth Management Group

Quarter filed	Position value	Share count	Share price at filing
2025-12-31	$774k	1.9k	397.65
2025-09-30	$933k	2.0k	456.00
2025-06-30	$706k	2.2k	326.09
2025-03-31	$737k	2.7k	270.02
2024-12-31	$327k	1.4k	235.31

More positions owned by Bannerman Wealth Management Group

Dimensional Etf Trust Us Core Equity 2 (DFAC)

Dimensional Etf Trust Core Fixed Incom (DFCF)

Dimensional Etf Trust Intl Core Eqt Mk (DFAI)

Dimensional Etf Trust Us Small Cap Etf (DFAS)

American Centy Etf Tr Us Large Cap Vlu (AVLV)

Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)

American Centy Etf Tr Intl Smcp Vlu (AVDV)

American Centy Etf Tr Emerging Mkt Val (AVES)

American Centy Etf Tr Us Eqt Etf (AVUS)

Ishares Tr Core Intl Aggr (IAGG)

Dimensional Etf Trust Us Real Estate E (DFAR)

NVIDIA Corporation (NVDA)

American Centy Etf Tr Avantis Core Fi (AVIG)

Ishares Tr Rus 1000 Val Etf (IWD)

View all positions for Bannerman Wealth Management Group

Top funds holding Alnylam Pharmaceuticals

Capital World Investors

Capital Research Global Investors

Jpmorgan Chase & Co

State Street Corporation

Geode Capital Management

Baillie Gifford & Co

Norges Bank Investment Management

Wellington Management Company

T. Rowe Price Investment Management

Orbis Allan Gray

View all funds holding Alnylam Pharmaceuticals

© 2026 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z